OR WAIT null SECS
March 19, 2026
Video
March 18, 2026
Neuen reflects on new FIND-CKD data suggesting finerenone’s benefit in nondiabetic chronic kidney disease and highlights urgency of early screening and combination therapy.
Data from 39 kidney biopsies may challenge longterm beliefs about diabetic nephropathy in CKD.
March 17, 2026
Should clinicians consider neighborhood disadvantage the same way they measure proteinuria and GFR for kidney health?
Article
KDIGO Launches Focused Update to 2024 CKD Guideline on Emerging Therapies
Allocating lower but acceptable quality kidneys to high-risk patients could introduce equity.
March 16, 2026
Phase 3 FIND-CKD shows finerenone slows non-diabetic CKD decline by improving eGFR slope; Bayer prepares FDA filing for expanded use.
March 13, 2026
New CKD therapies and a cardiometabolic care model are reshaping kidney disease management.
March 12, 2026
Experts discuss gaps in CKD detection, the role of albuminuria testing, and the need for earlier, risk-based care to improve outcomes.